3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
11
Lung Neoplasms
3
Neuroblastoma
2
Recurrence
1
Non-Small Cell Lung Cancer ALK-positive
1
Non Small Cell Lung Cancer Metastatic
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Hereditary Sensory and Autonomic Neuropathies
1
Glioma
1
Glioblastoma
1
Ganglioneuroblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
Carboplatin
9
pembrolizumab
7
Pemetrexed
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiation
4
Nivolumab
4
Bevacizumab
4
Platinum
3
Paclitaxel
3
Mastectomy, Segmental
3
Cisplatin
3
Biopsy
3
fludarabine phosphate
2
durvalumab
2
capmatinib
2
aldesleukin
2
Taxes
2
Radiotherapy, Conformal
2
Radiosurgery
2
Ipilimumab
2
Interleukin-2
2
Immunoglobulin G
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
Anterior Temporal Lobectomy
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
lorlatinib
×
1 year
×
Clear all
No trials found.